+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Postpartum Depression Treatment Market by Treatment Type (Non-Pharmacological, Pharmacological), Treatment Setting (Inpatient, Outpatient), Patient Severity, Distribution Channel - Global Forecast 2025-2030- Product Image
Postpartum Depression Treatment Market by Treatment Type (Non-Pharmacological, Pharmacological), Treatment Setting (Inpatient, Outpatient), Patient Severity, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Postpartum Depression Treatment Market by Treatment Type (Non-Pharmacological, Pharmacological), Treatment Setting (Inpatient, Outpatient), Patient Severity, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5639504
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Postpartum Depression Treatment Market grew from USD 1.02 billion in 2024 to USD 1.12 billion in 2025. It is expected to continue growing at a CAGR of 8.84%, reaching USD 1.70 billion by 2030.

Establishing the Foundation of Postpartum Depression Treatment Strategies Through Insightful Analysis of Emerging Therapeutic Approaches and Patient Needs

The journey into postpartum depression treatment begins with understanding the complex interplay of biological, psychological, and sociocultural factors influencing maternal mental health. By examining the latest scholarly evidence alongside evolving patient narratives, this introduction lays a solid foundation for appreciating the nuances of clinical interventions and patient experiences alike.

Early recognition of symptoms, ranging from mood fluctuations to profound emotional distress, underscores the urgency of accessible and effective treatment pathways. Integrating this context with patient-centric perspectives illuminates the critical role of both traditional and emerging therapies. As you progress through this report, the framing provided here will serve as an essential guide to the multifaceted strategies driving care innovations.

Unraveling the Paradigm Shifts Reshaping the Postpartum Depression Treatment Landscape Amidst Technological Advancements and Changing Care Models

Rapid advancements in digital health platforms have catalyzed a paradigm shift in postpartum depression care, enabling real-time monitoring and personalized support. Concurrently, traditional therapeutic models are embracing evidence-based enhancements, merging cognitive interventions with technology-driven engagement tools. These transformative shifts signal a departure from one-size-fits-all approaches, steering the field toward more dynamic, patient-responsive frameworks.

Moreover, stakeholder collaboration has intensified, leading to integrated care pathways that span obstetric, pediatric, and mental health services. This convergence fosters continuity of care from prenatal screening to postnatal follow-up, highlighting the significance of shared data ecosystems. As a result, practitioners and policymakers are now better equipped to align treatment protocols with both clinical efficacy and patient satisfaction, setting new benchmarks for standard of care.

Evaluating the Aggregate Consequences of the 2025 United States Tariffs on Postpartum Depression Treatment Supply Chains and Patient Access

The implementation of the 2025 United States tariffs has ushered in a period of strategic realignment across treatment supply networks. Manufacturers and distributors have navigated increased input costs through regional diversification and localized production. While some cost burdens have been transferred downstream, collaborative negotiation strategies with suppliers have mitigated the impact on patient access to critical therapies.

In parallel, healthcare providers have adapted procurement policies to maintain continuity of non-pharmacological and pharmacological offerings. Regulatory agencies have demonstrated flexibility in approving alternative formulations and digital therapeutic platforms, ensuring that tariff-induced constraints do not compromise quality of care. Collectively, these adaptive measures illustrate a resilient ecosystem that balances economic pressures with unwavering commitment to maternal mental health.

Revealing the Multifaceted Segmentation Insights That Illuminate Treatment Type Setting Severity and Distribution Dynamics in Postpartum Care Markets

Treatment options are broadly categorized into non-pharmacological approaches such as cognitive behavioral therapy, digital therapeutics and interpersonal therapy alongside pharmacological solutions including atypical antidepressants, SNRIs and SSRIs. This dual framework underscores how patient preferences and clinical indications drive care pathways, fostering an environment where blended modalities become increasingly prevalent.

Patients receive care either in inpatient environments like general hospitals and specialty psychiatric centers or in outpatient settings such as clinics, homecare services and telemedicine platforms. These setting-based distinctions reflect evolving demands for flexibility, accessibility and continuity, particularly as remote interventions gain traction.

Severity stratification further refines treatment planning by differentiating mild, moderate and severe cases, ensuring that resource allocation aligns with clinical urgency. Distribution channels encompass hospital pharmacies, online pharmacies and retail pharmacies, each offering unique value propositions in terms of convenience, coverage and service integration. Together, these segmentation layers deliver a comprehensive lens for understanding market dynamics and patient-centric care opportunities.

Discerning Regional Variations in Postpartum Depression Treatment Trends Across Americas Europe Middle East Africa and Asia Pacific Markets

Across the Americas, the emphasis on integrated care models and telehealth solutions has accelerated access to postpartum depression treatments, driven by robust healthcare infrastructure and insurance coverage frameworks. In Europe, Middle East & Africa, varying regulatory landscapes and reimbursement policies have shaped diverse adoption rates, with digital therapeutics gaining ground in urban centers while traditional therapies remain predominant in regions with limited connectivity.

Meanwhile, Asia-Pacific markets demonstrate a dual trajectory: emerging economies are rapidly scaling community-based mental health initiatives, whereas advanced economies are pioneering precision medicine approaches to maternal mental health. These regional variations highlight the necessity for tailored market entry strategies that respect local regulatory environments, cultural attitudes toward mental health and infrastructure capabilities.

Ultimately, recognizing these geographic nuances empowers industry stakeholders to tailor their offerings and engagement models, fostering more effective and equitable access to postpartum depression care.

Highlighting the Strategic Initiatives and Competitive Dynamics of Leading Companies Advancing Postpartum Depression Treatment Innovations

Leading stakeholders in the pharmaceutical sector have intensified collaboration with mental health specialists to co-develop innovative compounds that address both symptom relief and neurobiological resilience. Simultaneously, digital health pioneers have forged partnerships with clinical research organizations to validate platform efficacy, leveraging real-world evidence to enhance credibility among payers and providers.

Additionally, strategic alliances between technology firms and behavioral health networks have yielded seamless care coordination tools that integrate electronic health records with teletherapy modules. These cross-sector initiatives illustrate a growing convergence of expertise, designed to accelerate product development cycles and improve patient engagement. As market competition intensifies, companies that harmonize scientific rigor with user-centric design are poised to lead the next wave of treatment breakthroughs.

Delivering Practical Strategic Recommendations for Industry Leaders to Enhance Treatment Accessibility Efficiency and Patient Outcomes in Postpartum Care

Industry leaders should prioritize the development of customizable care pathways that integrate pharmacological and non-pharmacological interventions, thereby addressing the full spectrum of patient needs. Embracing interoperable digital platforms will enhance data sharing across obstetric and mental health providers, fostering seamless treatment journeys.

Furthermore, organizations are advised to cultivate strategic partnerships with regional healthcare systems to navigate tariff and reimbursement complexities, ensuring consistent supply chain resilience. Investing in real-world evidence generation through longitudinal patient registries can substantiate long-term efficacy and support favorable policy decisions. By adopting a patient-centric mindset, leaders can refine outreach strategies, reducing stigma and promoting early intervention.

Ultimately, a proactive approach to regulatory alignment and cross-sector collaboration will position companies to capture emerging opportunities and deliver superior maternal mental health outcomes.

Detailing the Rigorous Research Methodology Underpinning Postpartum Depression Treatment Analysis Including Data Sources and Analytical Frameworks

This analysis is grounded in a structured research methodology that synthesizes multiple data streams, including peer-reviewed journals, regulatory publications and expert interviews with clinicians, payers and policy advisors. Economic and tariff databases were consulted to evaluate the impact of trade policies on treatment supply chains, while proprietary digital health usage metrics informed assessments of patient engagement.

Qualitative insights were enriched by thematic analysis of patient testimonials and healthcare provider feedback, ensuring that the report captures both quantitative trends and lived experiences. Cross-validation techniques were employed to corroborate findings, and sensitivity analyses were conducted to identify critical drivers of market evolution. Together, these rigorous methods establish a transparent, reproducible framework for deriving actionable insights.

Summarizing Critical Insights and Strategic Implications Derived From Comprehensive Analysis of Postpartum Depression Treatment Trends and Challenges

The confluence of advanced therapeutic modalities, digital health integration and adaptive supply chain strategies has redefined the postpartum depression treatment landscape. Key segmentation insights reveal how treatment type, setting, severity and distribution channels intersect to shape patient journeys and market priorities.

Regional analyses underscore the importance of context-specific approaches, while competitive dynamics illustrate the value of strategic alliances in driving innovation. Regulatory influences, particularly the 2025 tariff adjustments, have tested the resilience of supply networks, prompting creative procurement and distribution solutions.

By synthesizing these insights, this report equips decision-makers with a coherent narrative on the current state of postpartum depression care and the strategic imperatives for future growth. The conclusion reaffirms the necessity of patient-centric, data-driven strategies to address evolving industry challenges and optimize maternal mental health outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Treatment Type
    • Non-Pharmacological
      • Cognitive Behavioral Therapy
      • Digital Therapeutics
      • Interpersonal Therapy
    • Pharmacological
      • Atypical Antidepressants
      • Snris
      • Ssris
  • Treatment Setting
    • Inpatient
      • General Hospital
      • Specialty Psychiatric Center
    • Outpatient
      • Clinic
      • Homecare
      • Telemedicine
  • Patient Severity
    • Mild
    • Moderate
    • Severe
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Eli Lilly and Company
  • H. Lundbeck A/S
  • AbbVie Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Sage Therapeutics, Inc.
  • Sumitomo Pharma Co., Ltd.
  • Sunovion Pharmaceuticals Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Telehealth platforms offering on-demand cognitive behavioral therapy modules specifically tailored for postpartum depression support mothers outside clinical settings
5.2. Pharmacogenomic testing informing personalized antidepressant selection to reduce trial-and-error treatment delays in postpartum depression care
5.3. Introduction of rapid-acting neuroactive steroids such as zuranolone and brexanolone to provide faster symptom relief for new mothers
5.4. Expansion of insurance reimbursement policies covering telepsychiatry and home-based interventions for postpartum mood disorders
5.5. Integration of AI-driven predictive analytics into obstetric care pathways to identify women at high risk of developing postpartum depression
5.6. Growth of digital peer support communities moderated by licensed therapists to enhance maternal mental health outcomes post childbirth
5.7. Adoption of noninvasive neuromodulation therapies like TMS and tDCS in clinical protocols for treatment-resistant postpartum depression
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Postpartum Depression Treatment Market, by Treatment Type
8.1. Introduction
8.2. Non-Pharmacological
8.2.1. Cognitive Behavioral Therapy
8.2.2. Digital Therapeutics
8.2.3. Interpersonal Therapy
8.3. Pharmacological
8.3.1. Atypical Antidepressants
8.3.2. Snris
8.3.3. Ssris
9. Postpartum Depression Treatment Market, by Treatment Setting
9.1. Introduction
9.2. Inpatient
9.2.1. General Hospital
9.2.2. Specialty Psychiatric Center
9.3. Outpatient
9.3.1. Clinic
9.3.2. Homecare
9.3.3. Telemedicine
10. Postpartum Depression Treatment Market, by Patient Severity
10.1. Introduction
10.2. Mild
10.3. Moderate
10.4. Severe
11. Postpartum Depression Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Americas Postpartum Depression Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Postpartum Depression Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Postpartum Depression Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Pfizer Inc.
15.3.2. GlaxoSmithKline plc
15.3.3. Johnson & Johnson
15.3.4. Eli Lilly and Company
15.3.5. H. Lundbeck A/S
15.3.6. AbbVie Inc.
15.3.7. Otsuka Pharmaceutical Co., Ltd.
15.3.8. Sage Therapeutics, Inc.
15.3.9. Sumitomo Pharma Co., Ltd.
15.3.10. Sunovion Pharmaceuticals Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. POSTPARTUM DEPRESSION TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2030 (%)
FIGURE 8. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. POSTPARTUM DEPRESSION TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. POSTPARTUM DEPRESSION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. POSTPARTUM DEPRESSION TREATMENT MARKET: RESEARCHAI
FIGURE 24. POSTPARTUM DEPRESSION TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. POSTPARTUM DEPRESSION TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. POSTPARTUM DEPRESSION TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. POSTPARTUM DEPRESSION TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INTERPERSONAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INTERPERSONAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ATYPICAL ANTIDEPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ATYPICAL ANTIDEPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SNRIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SNRIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SSRIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SSRIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY GENERAL HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY GENERAL HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SPECIALTY PSYCHIATRIC CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SPECIALTY PSYCHIATRIC CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TELEMEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TELEMEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY MILD, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY MILD, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY MODERATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY MODERATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SEVERE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SEVERE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 103. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 104. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 105. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 106. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 107. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 108. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 109. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 110. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 111. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 112. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 113. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 114. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 115. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 116. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 117. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 122. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 123. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 124. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 125. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 126. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 127. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 128. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 129. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 130. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 131. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 132. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 133. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 202. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 203. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 204. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 205. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 206. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 207. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 208. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 209. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 210. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 211. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 212. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 213. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 214. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 215. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 220. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 221. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 222. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 223. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 224. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 225. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 226. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 227. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 228. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 229. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 230. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 231. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 250. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 251. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 252. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 253. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 254. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 255. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 256. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 257. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 258. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 259. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 260. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 261. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 262. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 263. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 266. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 267. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 268. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 269. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 270. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 271. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 272. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 273. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 274. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 275. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 276. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 277. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 278. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 279. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PATIENT SEVERITY, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA POSTPARTUM DEPRESSION TREATMEN

Samples

Loading
LOADING...

Companies Mentioned

  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Eli Lilly and Company
  • H. Lundbeck A/S
  • AbbVie Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Sage Therapeutics, Inc.
  • Sumitomo Pharma Co., Ltd.
  • Sunovion Pharmaceuticals Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.7 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Postpartum Depression Drugs - Global Strategic Business Report - Product Image

Postpartum Depression Drugs - Global Strategic Business Report

  • Report
  • 479 Pages
  • Global
From
Postpartum Depression Market Report 2025 - Product Image

Postpartum Depression Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Postpartum Depression Epidemiology Forecast 2025-2034 - Product Image

Postpartum Depression Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Anxiety Disorders and Depression Treatment Market Size, Share & Trends Analysis Report by Drug Type, Indication (Depression, Anxiety), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Anxiety Disorders and Depression Treatment Market Size, Share & Trends Analysis Report by Drug Type, Indication (Depression, Anxiety), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Anxiety Disorders And Depression Treatment Global Market Report 2025 - Product Image

Anxiety Disorders And Depression Treatment Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From

About the Postpartum Depression Drug Market

The Postpartum Depression Drug market is a subset of the Mental Disorders Drugs market. Postpartum depression is a type of depression that can occur in women after childbirth. It is estimated to affect up to 20% of women after giving birth. Postpartum depression drugs are used to treat the symptoms of postpartum depression, such as sadness, anxiety, and fatigue. These drugs are typically prescribed by a doctor and can include antidepressants, psychotherapy, and hormone therapy. The Postpartum Depression Drug market is a growing market, with an increasing number of women being diagnosed with postpartum depression. The market is expected to continue to grow as more women seek treatment for postpartum depression. Some companies in the Postpartum Depression Drug market include Eli Lilly, Pfizer, GlaxoSmithKline, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.